Manufacturer copay assistance · Jemperli (J9272) · GSK
$0 · Maximum benefit Up to $26,000 per calendar year · Covers Jemperli drug cost only — patient is responsible for administration and office visit costs
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
Run a benefits estimate for Jemperli — the program's cap applies against the patient share CareCost calculates.
Yes — Jemperli Copay Program from GSK. Eligible commercially insured patients may pay as little as $0 per treatment. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Eligible commercially insured patients may pay as little as $0 per treatment Maximum benefit: Up to $26,000 per calendar year. Covers Jemperli drug cost only — patient is responsible for administration and office visit costs
Accepted insurance: commercial. Not eligible: medicare, medicaid, government.